EOLS
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
Head of Investor Relations
Establishment Labs Holdings Inc. (ESTA)Head of Investor Relations
Evolus, Inc. (EOLS)Equibles does not estimate personal net worth.
Get an email with a short summary when Establishment Labs Holdings Inc. publishes a filing, an earnings call transcript or a press release.
Get ESTA alertsDavid Erickson is recorded as Head of Investor Relations at Establishment Labs Holdings Inc. (ESTA) and Head of Investor Relations at Evolus, Inc. (EOLS). David Erickson has spoken on 9 earnings calls across 2 companies, most recently for Evolus, Inc. on August 2, 2023. Those appearances were for Evolus, Inc. (EOLS) and Establishment Labs Holdings Inc. (ESTA). Evolus, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Establishment Labs Holdings Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Evolus, Inc. includes David Moatazedi (CFO and Board Member), Albert G. White III (Board Member), Albert White III (Board Member) and 4 others.
“Our prepared remarks today will include forward-looking statements within the meaning of United States Securities Laws and management may make additional forward-looking statements in response to your questions.”
“Our prepared remarks today will include forward-looking statements within the meaning of United States Securities Laws and management may make additional forward-looking statements in response to your questions.”
“Our prepared remarks today will include forward-looking statements within the meaning of United States Securities Laws, and management may make additional forward-looking statements in response to your questions.”
“Forward-looking statements are based on management's current assumptions and expectations of future events and trends, which may affect the company's business, strategy, operations, or financial performance.”
“Our prepared remarks today will include forward-looking statements within the meaning of United States securities laws, and management may make additional forward-looking statements in response to your questions.”
EOLS
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
Medical Devices · Healthcare
Head of Investor Relations